CN1823752A - 含对乙酰氨基酚的软胶囊组合物 - Google Patents
含对乙酰氨基酚的软胶囊组合物 Download PDFInfo
- Publication number
- CN1823752A CN1823752A CN 200510022503 CN200510022503A CN1823752A CN 1823752 A CN1823752 A CN 1823752A CN 200510022503 CN200510022503 CN 200510022503 CN 200510022503 A CN200510022503 A CN 200510022503A CN 1823752 A CN1823752 A CN 1823752A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- acetaminophen
- capsule composition
- active component
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 35
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title claims description 56
- 229960005489 paracetamol Drugs 0.000 title claims description 28
- 239000000203 mixture Substances 0.000 title description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 15
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 15
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 claims abstract description 11
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 claims abstract description 11
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 claims abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 30
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 16
- 239000007963 capsule composition Substances 0.000 claims description 12
- YQSHYGCCYVPRDI-UHFFFAOYSA-N (4-propan-2-ylphenyl)methanamine Chemical compound CC(C)C1=CC=C(CN)C=C1 YQSHYGCCYVPRDI-UHFFFAOYSA-N 0.000 claims description 10
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 10
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 10
- 229960003782 dextromethorphan hydrobromide Drugs 0.000 claims description 10
- 239000001632 sodium acetate Substances 0.000 claims description 10
- 235000017281 sodium acetate Nutrition 0.000 claims description 10
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims description 9
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 9
- 229920001223 polyethylene glycol Polymers 0.000 claims description 9
- 235000011056 potassium acetate Nutrition 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 5
- 229960001948 caffeine Drugs 0.000 claims description 5
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- -1 bagodryl hydrochloride Chemical compound 0.000 abstract 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 8
- 239000000470 constituent Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000008188 pellet Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000005352 clarification Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- ADVGKWPZRIDURE-UHFFFAOYSA-N 2'-Hydroxyacetanilide Chemical compound CC(=O)NC1=CC=CC=C1O ADVGKWPZRIDURE-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Abstract
Description
PH值 | PH=7.8 | PH=6.9 | PH=5.0 |
现象 | 药液压制成软胶囊,经铝塑泡罩包装(12粒/板),随机抽取10板(120粒)做加速试验,5天后48粒出现漏液,10天后70粒出现漏液 | 药液压制成软胶囊,经铝塑泡罩包装(12粒/板),随机抽取10板(120粒)做加速试验,3个月未出现形状改变 | 药液放置24小时后,出现结晶析出 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510022503XA CN100364521C (zh) | 2005-12-22 | 2005-12-22 | 含对乙酰氨基酚的软胶囊组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510022503XA CN100364521C (zh) | 2005-12-22 | 2005-12-22 | 含对乙酰氨基酚的软胶囊组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1823752A true CN1823752A (zh) | 2006-08-30 |
CN100364521C CN100364521C (zh) | 2008-01-30 |
Family
ID=36934697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510022503XA Expired - Fee Related CN100364521C (zh) | 2005-12-22 | 2005-12-22 | 含对乙酰氨基酚的软胶囊组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100364521C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446153A (zh) * | 2013-08-16 | 2013-12-18 | 安士制药(中山)有限公司 | 一种夜用治疗感冒的组合物及软胶囊 |
CN109512794A (zh) * | 2018-12-24 | 2019-03-26 | 浙江安宝药业有限公司 | 扑热息痛软胶囊 |
CN112755034A (zh) * | 2021-03-22 | 2021-05-07 | 四川诺远药业有限公司 | 一种复方酚咖伪麻胶囊生产工艺 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5505961A (en) * | 1993-08-05 | 1996-04-09 | R. P. Scherer Corporation | Gelatin capsules containing a highly concentrated acetaminophen solution |
-
2005
- 2005-12-22 CN CNB200510022503XA patent/CN100364521C/zh not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446153A (zh) * | 2013-08-16 | 2013-12-18 | 安士制药(中山)有限公司 | 一种夜用治疗感冒的组合物及软胶囊 |
CN103446153B (zh) * | 2013-08-16 | 2016-04-06 | 安士制药(中山)有限公司 | 一种夜用治疗感冒的组合物及软胶囊 |
CN109512794A (zh) * | 2018-12-24 | 2019-03-26 | 浙江安宝药业有限公司 | 扑热息痛软胶囊 |
CN112755034A (zh) * | 2021-03-22 | 2021-05-07 | 四川诺远药业有限公司 | 一种复方酚咖伪麻胶囊生产工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN100364521C (zh) | 2008-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1213754C (zh) | β-咔啉药物组合物 | |
CN1089471A (zh) | 稳定的延长释放口服组合物 | |
CN1589139A (zh) | 调节释放坦洛新片剂 | |
CN1883458A (zh) | 兰索拉唑钠肠溶制剂及其制备方法 | |
CN1863510A (zh) | 用于治疗剂的微-粒子脂肪酸盐固体剂量制剂 | |
CN1823752A (zh) | 含对乙酰氨基酚的软胶囊组合物 | |
CN1420780A (zh) | 含有藻酸盐的药物组合物 | |
CN1887292A (zh) | 一种香菇多糖软胶囊及其制备方法 | |
CN1875949A (zh) | 天麻素软胶囊及其制备方法 | |
CN1911251A (zh) | 一种以鲜地龙提取物为活性成分的中药肠溶口服制剂及其制备方法 | |
CN101057837A (zh) | 一种右旋酮洛芬肠溶微丸及制备方法 | |
CN1729979A (zh) | 黄藤素软胶囊组合物 | |
CN1857263A (zh) | 含葡萄糖酸锌、布洛芬和马来酸氯苯那敏的软胶囊组合物 | |
CN1289076C (zh) | 包含利托那韦的可溶性稳定药物组合物及制备浓缩的药物组合物的方法 | |
CN100341508C (zh) | 一种复方抗感冒药物的软胶囊组合物 | |
CN1500491A (zh) | 口服罗红霉素控释制剂 | |
CN1644202A (zh) | 葫芦素液体型组方及其制剂 | |
CN1923207A (zh) | 一种复方维生素冻干粉针剂及其制备方法 | |
CN100336501C (zh) | 醋炎痛缓释性圆粒组成物及制备方法 | |
CN1788738A (zh) | 一种含挥发油的药物制剂及其制备方法 | |
CN1562065A (zh) | 盐酸阿霉素脂质体制剂及其制备方法 | |
CN1582949A (zh) | 一种阿仑膦酸盐肠溶制剂及其制备方法 | |
CN1562043A (zh) | 爱普列特滴丸及其制备方法 | |
CN1686120A (zh) | 氢溴酸高乌甲素滴丸及其制备方法 | |
CN1686128A (zh) | 多潘立酮滴丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20130701 Granted publication date: 20080130 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20140101 Granted publication date: 20080130 |
|
PD01 | Discharge of preservation of patent | ||
PP01 | Preservation of patent right |
Effective date of registration: 20140101 Granted publication date: 20080130 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20140623 Granted publication date: 20080130 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080130 Termination date: 20131222 |